Biohaven falls after depression drug fails mid-stage trial
U.S. STOCKS ON THE MOVE-Adicet Bio, Coupang, Biohaven,
U.S. STOCKS ON THE MOVE-Biohaven, silver miners, gold miners
Biohaven falls after depression drug fails mid-stage trial
Biohaven's depression drug fails mid-stage trial, shares fall
Biohaven falls after depression drug fails mid-stage trial
U.S. STOCKS ON THE MOVE-Walt Disney, Titan Mining, Costco Wholesale
Biohaven jumps as cancer treatment shows promise in early-stage trial
U.S. RESEARCH ROUNDUP- Agios Pharmaceuticals, Dycom Industries, Lowe's Companies
U.S. STOCKS ON THE MOVE-TransDigm, Citigroup, Cisco Systems
U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold miners
U.S. STOCKS ON THE MOVE-ExxonMobil, Yatra, Venture Global
Biohaven slumps on pricing $175 mln stock deal
Biohaven slumps after $150 mln stock sale plans announced
Brief: Biohaven Announces Proposed Public Offering Of Common Shares
Biopharma firm Biohaven's Q3 net loss widens to $173.4 mln
U.S. RESEARCH ROUNDUP-Acadia Pharmaceuticals, Applovin Corp, Centuri Holdings
U.S. STOCKS ON THE MOVE-Targa Resources, Illumina, Alphabet
U.S. STOCKS ON THE MOVE-Bunge, O'Reilly Automotive, Targa Resources